FDA gets power to revoke decades-old food additive approvals

What it does

This bill creates a federal review board to examine food additives that manufacturers claimed were safe before 2000 without formal FDA approval. The board will categorize these substances by risk level and decide whether to revoke their 'safe' status; manufacturers have 180 days to prove safety or face removal of their products from the market. The bill empowers the FDA to penalize manufacturers who don't disclose which additives they're using and treats undisclosed substances as unapproved and unsafe.

Why we flagged it

The bill's operative mechanism is a regulatory review and revocation authority, not a new safety standard or research mandate. It empowers the FDA to audit and challenge decades-old industry self-designations of safety, with enforcement teeth (civil penalties, product removal).

What the text implies

• The 180-day cure period may be insufficient for manufacturers to generate new safety data on substances in use for 25+ years; many may simply withdraw products rather than fund studies, potentially disrupting supply chains for common food ingredients.
• Board membership includes a food manufacturing industry representative as a non-voting member, giving industry insight into review priorities and evidence standards but no formal veto; this may soften enforcement or create perception of capture.
• The 10-year sunset clause means the board dissolves after reviewing all tiers, leaving no permanent mechanism to challenge GRAS designations made between 2000 and enactment; a future Congress would need to reauthorize to extend oversight.
• Manufacturers must self-report covered GRAS designations under penalty of civil fines or product seizure; non-compliance triggers automatic treatment as unapproved and unsafe, creating strong incentive to disclose but also potential for over-reporting to avoid penalties.

Section numbers refer to the bill text the analysis read — linked under Primary records below.

Who it affects

Citizens gain transparency and safety review of food additives that entered the market without formal FDA approval or public disclosure. Manufacturers face enforcement pressure to prove safety or withdraw products, shifting the burden of proof from consumers to industry and reducing exposure to potentially unsafe substances.

Who stands to gain

• Food safety testing and consulting firms (will conduct safety studies for manufacturers during 180-d
• Regulatory compliance consultants and law firms specializing in FDA matters

Named in the bill

Food and Drug Administration (FDA), Department of Agriculture (USDA), Environmental Protection Agency (EPA), Food Safety and Inspection Service (FSIS), Center for Nutrition Policy and Promotion, Agricultural Research Service, Public Health and Integrated Toxicology Division (EPA), Food manufacturers (regulated parties)

Where it stands

1 cosponsor: 1 Democrats.

• Jan 30, 2026 — Introduced · Congress.gov: “Introduced in House”
• Jan 30, 2026 — Referred to House Committee on Energy and Commerce · Congress.gov: “Referred to the House Committee on Energy and Commerce”

Dates and quoted wording are Congress.gov's action record; the timeline shows status changes, not every procedural step.

Money around this bill

7 lobbying clients named this bill on 8 disclosure filings across 2 quarters, Mar 2026 to Jun 2026. Those filings disclosed $37,449,750 in lobbying spend. A filing names 23 bills on average, so that figure is what each filing reported, not a share belonging to this bill.

More lobbying clients named this bill than 86% of bills with at least one filing.

Michael Lawler, the sponsor, reported $2,042,071 in PAC receipts in the 2026 cycle.

• Chamber of Commerce of the U.S.A. — $36,700,000 on 2 filings
• International Dairy Foods Association — $270,000 on 1 filing
• Consumer Healthcare Products Association — $199,750 on 1 filing
• Unilever United States, Inc. — $130,000 on 1 filing
• Pharmavite LLC — $90,000 on 1 filing

Lobbying Disclosure Act filings through Jul 20, 2026. A filing shows who paid to lobby on a bill it names, not what changed.